Soluble CD163 is a predictor of fibrosis and hepatocellular carcinoma development in nonalcoholic steatohepatitis

BACKGROUND: Nonalcoholic fatty liver disease (NAFLD) is the most common cause of chronic liver disease. The serum level of soluble CD163 (sCD163), a macrophage activation marker, is associated with liver tissue changes; however, its prognostic value is unknown. Here, we determined the utility of sCD...

Descripción completa

Detalles Bibliográficos
Autores principales: Kawanaka, Miwa, Nishino, Ken, Kawada, Mayuko, Ishii, Katsunori, Tanikawa, Tomohiro, Katsumata, Ryo, Urata, Noriyo, Nakamura, Jun, Suehiro, Mitsuhiko, Haruma, Ken, Kawamoto, Hirofumi
Formato: Online Artículo Texto
Lenguaje:English
Publicado: BioMed Central 2023
Materias:
Research
Acceso en línea:https://www.ncbi.nlm.nih.gov/pmc/articles/PMC10173513/
https://www.ncbi.nlm.nih.gov/pubmed/37165352
http://dx.doi.org/10.1186/s12876-023-02786-4

Internet

https://www.ncbi.nlm.nih.gov/pmc/articles/PMC10173513/
https://www.ncbi.nlm.nih.gov/pubmed/37165352
http://dx.doi.org/10.1186/s12876-023-02786-4

Ejemplares similares